XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained (Deficit) Earnings
Accumulated Other Comprehensive Loss
Noncontrolling Interest
AOCI Attributable to Parent
AOCI Including Portion Attributable to Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2020   30,685,938              
Beginning balance at Dec. 31, 2020 $ 326,598,000 $ 307,000 $ 294,643,000 $ 0 $ 34,792,000 $ (3,144,000)   $ (3,144,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Release of restricted stock (in shares)   23,811              
Release of restricted stock (990,000) $ 0 (990,000)            
Share-based compensation 4,483,000   4,483,000            
Stock options exercised (in shares)   30,000              
Stock options exercised 129,000   129,000            
Penny warrants exercised (in shares)   932,949              
Penny warrants exercised 0 $ 9,000   9,000          
Adjustments To Additional Paid In Capital, Reclassification Of Options 59,724,000   59,724,000            
Adjustments To Additional Paid In Capital, Issuance Of Warrants 64,694,000   64,694,000            
Stock issued for equity purchase (in shares)   221,391              
Stock issued for equity purchase 11,776,000 $ 2,000 11,774,000            
Other comprehensive income (loss) (1,012,000)               $ (1,012,000)
Net income (10,705,000)       (10,705,000)        
Ending balance (in shares) at Mar. 31, 2021   31,894,089              
Ending balance at Mar. 31, 2021 454,697,000 $ 318,000 434,457,000 (9,000) 24,087,000 (4,156,000)      
Beginning balance (in shares) at Dec. 31, 2020   30,685,938              
Beginning balance at Dec. 31, 2020 326,598,000 $ 307,000 294,643,000 0 34,792,000 (3,144,000)   (3,144,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Other comprehensive income (loss) (552,000)                
Net income 58,237,000                
Ending balance (in shares) at Jun. 30, 2021   44,591,127              
Ending balance at Jun. 30, 2021 1,367,224,000 $ 445,000 1,363,779,000 0 6,696,000 (3,696,000)   (3,696,000)  
Beginning balance (in shares) at Mar. 31, 2021   31,894,089              
Beginning balance at Mar. 31, 2021 454,697,000 $ 318,000 434,457,000 (9,000) 24,087,000 (4,156,000)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Release of restricted stock (in shares)   9,181              
Release of restricted stock 3,901,000 $ 0 (205,000) (116,000)          
Share-based compensation 3,901,000   3,901,000            
Stock options exercised (in shares)   40,000              
Stock options exercised 172,000   172,000            
Retirement of treasury shares 0 $ 21,000 28,488,000 114,842,000 86,333,000        
Common stock offering (in shares)   12,650,000              
Common stock offering 667,873,000 $ 127,000 667,746,000            
Sinclair shares exchanged for penny warrants (in shares)   (2,086,908)              
Sinclair shares exchanged for penny warrants 0   (114,717,000) (114,717,000)          
Sinclair issuance of penny warrants 50,000,000   50,000,000            
Stock issued for equity purchase (in shares)   2,084,765              
Stock issued for equity purchase 121,500,000 $ 21,000 121,479,000            
Other comprehensive income (loss) 460,000               460,000
Net income 68,942,000       68,942,000        
Ending balance (in shares) at Jun. 30, 2021   44,591,127              
Ending balance at Jun. 30, 2021 1,367,224,000 $ 445,000 1,363,779,000 0 6,696,000 $ (3,696,000)   (3,696,000)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1,615,802,000           $ 3,760,000    
Beginning balance (in shares) at Dec. 31, 2021   52,254,477              
Beginning balance at Dec. 31, 2021 1,612,042,000 $ 530,000 1,849,068,000 (29,166,000) (181,581,000)     (26,809,000) (26,809,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Release of restricted stock (in shares)   122,849              
Release of restricted stock (2,533,000) $ 1,000 (2,534,000)            
Share-based compensation 5,095,000   5,095,000            
Stock options exercised (in shares)   20,000              
Stock options exercised 86,000   86,000            
Penny warrants exercised (in shares)   383,934              
Penny warrants exercised 4,000 $ 4,000              
Adjustments To Additional Paid In Capital, Issuance Of Warrants 12,010,000   12,010,000            
Retirement of treasury shares 0 $ 11,000 35,200,000 42,454,000 7,243,000        
Share repurchases (in shares)   (350,616)              
Treasury Stock, Value, Acquired, Cost Method (13,288,000)     (13,288,000)          
Stock issued for equity purchase (in shares)   107,832              
Stock issued for equity purchase 3,700,000 $ 1,000 3,699,000            
Other comprehensive income (loss) (71,542,000)               (71,542,000)
Net income 1,889,000       1,889,000        
Ending balance (in shares) at Mar. 31, 2022   52,538,476              
Ending balance at Mar. 31, 2022   $ 525,000 1,832,224,000 0 (186,935,000)       (98,351,000)
Beginning balance (in shares) at Dec. 31, 2021   52,254,477              
Beginning balance at Dec. 31, 2021 1,612,042,000 $ 530,000 1,849,068,000 (29,166,000) (181,581,000)     (26,809,000) (26,809,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Noncontrolling Interest, Increase from Business Combination $ 3,760,000                
Share repurchases (in shares) (350,616)                
Treasury Stock, Value, Acquired, Cost Method $ (13,288,000)                
Other comprehensive income (loss) (270,355,000)                
Net income 61,390,000                
Ending balance (in shares) at Jun. 30, 2022   52,577,251              
Ending balance at Jun. 30, 2022 1,414,165,000 $ 525,000 1,838,238,000 0 (127,434,000)     (297,164,000) (297,164,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1,551,223,000           3,760,000    
Beginning balance (in shares) at Mar. 31, 2022   52,538,476              
Beginning balance at Mar. 31, 2022   $ 525,000 1,832,224,000 0 (186,935,000)       (98,351,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Release of restricted stock (in shares)   38,775              
Release of restricted stock (308,000)   (308,000) 0          
Share-based compensation 6,322,000   6,322,000            
Other comprehensive income (loss) (198,813,000)               (198,813,000)
Net income 59,501,000       59,501,000        
Ending balance (in shares) at Jun. 30, 2022   52,577,251              
Ending balance at Jun. 30, 2022 1,414,165,000 $ 525,000 $ 1,838,238,000 $ 0 $ (127,434,000)     $ (297,164,000) $ (297,164,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 1,417,925,000           $ 3,760,000